Use of copeptin and high-sensitive cardiac troponin T for diagnosis and prognosis in patients with diabetes mellitus and suspected acute myocardial infarction

International Journal of Cardiology

Volumn 190, Issue 1, 2015, Pages 190-197

  Zellweger, C ^a   Wildi, K ^a   Twerenbold, R ^a   Reichlin, T ^a   Naduvilekoot, A ^a   Neuhaus, J D ^a   Balmelli, C ^a   Gabutti, M ^a   Afify, A Al ^b   Ballarino, P ^c   Jager C ^a   Druey, S ^a   Haaf, P ^a   Vilaplana, C ^d   Darbouret, B ^e   Ebmeyer, S ^e   Gimenez, M Rubini ^a   Moehring, B ^a   Osswald, S ^a   Mueller, C ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b TANTA UNIVERSITY   (Egypt)

^c UNIVERSITY OF GENOA   (Italy)

^d HOSPITAL DEL MAR   (Spain)

^e THERMO FISHER SCIENTIFIC   (Germany)

Author keywords

Acute myocardial infarction; Conventional cardiac troponin; Copeptin; Diabetes; High sensitive cardiac troponin

Indexed keywords

BIOLOGICAL MARKER; COPEPTIN; HIGH SENSITIVE TROPONIN T; TROPONIN T; UNCLASSIFIED DRUG; GLYCOPEPTIDE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR DIAGNOSIS; MULTICENTER STUDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SURVIVAL RATE; BLOOD; CLINICAL TRIAL; INTERNATIONAL COOPERATION; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; PROSPECTIVE STUDY; TRENDS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOMARKERS; COHORT STUDIES; DIABETES MELLITUS; EARLY DIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; GLYCOPEPTIDES; HUMANS; INTERNATIONALITY; MALE; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; PROGNOSIS; PROSPECTIVE STUDIES; TROPONIN T;

EID: 84929335430     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.04.134     Document Type: Article

References (39)

1. T. Almdal, H. Scharling, J.S. Jensen, H. Vestergaard, The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up, Arch. Intern. Med. 164 (2004) 1422-1426.
2. S.M. Haffner, S. Lehto, T. Rönnemaa, K. Pyörälä, M. Laakso, Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction, N. Engl. J. Med. 339 (1998) 229-234.
3. S.M. Donahoe, G.C. Stewart, C.H. McCabe, S. Mohanavelu, S.A. Murphy, C.P. Cannon, et al., Diabetes and mortality following acute coronary syndromes, JAMA 298 (2007) 765-775.
4. E. Niakan, Y. Harati, L.A. Rolak, J.P. Comstock, R. Rokey, Silent myocardial infarction and diabetic cardiovascular autonomic neuropathy, Arch. Intern. Med. 146 (1986) 2229-2230.
5. K. Ranjadayalan, V. Umachandran, G. Ambepityia, P.G. Kopelman, P.G. Mills, A.D. Timmis, Prolonged anginal perceptual threshold in diabetes: effects on exercise capacity and myocardial ischemia, J. Am. Coll. Cardiol. 16 (1990) 1120-1124.
6. J.G. Canto, M.G. Shlipak, W.J. Rogers, J.A. Malmgren, P.D. Frederick, C.T. Lambrew, et al., Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain, JAMA 283 (2000) 3223-3229.
7. K. Franklin, R.J. Goldberg, F. Spencer, W. Klein, A. Budaj, D. Brieger, et al., Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events, Arch. Intern. Med. 164 (2004) 1457-1463.
8. K. Thygesen, J.S. Alpert, H.D. White, A.S. Jaffe, F.S. Apple, M. Galvani, et al., Universal definition of myocardial infarction, Circulation 116 (2007) 2634-2653.
9. S.E. Melanson, D.A. Morrow, P. Jarolim, Earlier detection of myocardial injury in a preliminary evaluation using a new troponin I assay with improved sensitivity, Am. J. Clin. Pathol. 128 (2007) 282-286.
10. T. Reichlin, W. Hochholzer, S. Bassetti, S. Steuer, C. Stelzig, S. Hartwiger, et al., Early diagnosis of myocardial infarction with sensitive cardiac troponin assays, N. Engl. J. Med. 361 (2009) 858-867.
11. T. Reichlin, W. Hochholzer, C. Stelzig, K. Laule, H. Freidank, N.G. Morgenthaler, et al., Incremental value of copeptin for rapid rule out of acute myocardial infarction, J. Am. Coll. Cardiol. 54 (2009) 60-68.
12. S.Q. Khan, O.S. Dhillon, R.J. O'Brien, J. Struck, P.A. Quinn, N.G. Morgenthaler, et al., C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study, Circulation 115 (2007) 2103-2110.
13. S. Enhörning, L. Bankir, N. Bouby, J. Struck, B. Hedblad, M. Persson, et al., Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmö Diet and Cancer Study cardiovascular cohort, Int. J. Obes. (Lond.) 37 (2013) 598-603.
14. S. Enhörning, T.J. Wang, P.M. Nilsson, P. Almgren, B. Hedblad, G. Berglund, et al., Plasma copeptin and the risk of diabetes mellitus, Circulation 121 (2010) 2102-2108.
15. T. Reichlin, A. Irfan, R. Twerenbold, M. Reiter, W. Hochholzer, H. Burkhalter, et al., Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction, Circulation 124 (2011) 136-145.
16. J.M. Woodforde, H. Merskey, Some relationships between subjective measures of pain, J. Psychosom. Res. 16 (1972) 173-178.
17. T. Reichlin, C. Schindler, B. Drexler, R. Twerenbold, M. Reiter, C. Zellweger, et al., One-hour rule-out and rule-in of acute myocardial infarction using highsensitivity cardiac troponin T, Arch. Intern. Med. 172 (2012) 1211-1218.
18. E. Giannitsis, K. Kurz, K. Hallermayer, J. Jarausch, A.S. Jaffe, H.A. Katus, Analytical validation of a high-sensitivity cardiac troponin T assay, Clin. Chem. 56 (2010) 254-261.
19. T. Keller, S. Tzikas, T. Zeller, E. Czyz, L. Lillpopp, F.M. Ojeda, et al., Copeptin improves early diagnosis of acute myocardial infarction, J. Am. Coll. Cardiol. 55 (2010) 2096-2106.
20. E.R. DeLong, D.M. DeLong, D.L. Clarke-Pearson, Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach, Biometrics 44 (1988) 837-845.
21. B. Elbarouni, N. Ismaeil, R.T. Yan, K.A.A. Fox, K.A. Connelly, C. Baer, et al., Temporal changes in the management and outcome of Canadian diabetic patients hospitalized for non-ST-elevation acute coronary syndromes, Am. Heart J. 162 (2011) 347-355 (.e1).
22. C. Ruperto, D. Capodanno, A. Blundo, P. Capranzano, A. Sanfilippo, A. Caggegi, et al., Impact of diabetes mellitus on long-term follow-up of percutaneous coronary intervention based on clinical presentation of coronary artery disease, J. Cardiovasc. Med. (Hagerstown) 12 (2011) 405-410.
23. K. Malmberg, S. Yusuf, H.C. Gerstein, J. Brown, F. Zhao, D. Hunt, et al., Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry, Circulation 102 (2000) 1014-1019.
24. L.O. Jensen, M. Maeng, P. Thayssen, H.H. Tilsted, C.J. Terkelsen, A. Kaltoft, et al., Influence of diabetes mellitus on clinical outcomes following primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction, Am. J. Cardiol. 109 (2012) 629-635.
25. N.G. Morgenthaler, J. Struck, C. Alonso, A. Bergmann, Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin, Clin. Chem. 52 (2006) 112-119.
26. S. Jochberger, N.G. Morgenthaler, V.D. Mayr, G. Luckner, V. Wenzel, H. Ulmer, et al., Copeptin and arginine vasopressin concentrations in critically ill patients, J. Clin. Endocrinol. Metab. 91 (2006) 4381-4386.
27. K. Itoi, Y.-Q. Jiang, Y. Iwasaki, S.J. Watson, Regulatory mechanisms of corticotropin-releasing hormone and vasopressin gene expression in the hypothalamus, J. Neuroendocrinol. 16 (2004) 348-355.
28. M. Katan, N. Morgenthaler, I. Widmer, J.J. Puder, C. König, B. Müller, et al., Copeptin, a stable peptide derived from the vasopressin precursor, correlates with the individual stress level, Neuro Endocrinol. Lett. 29 (2008) 341-346.
29. R.L. Zerbe, F. Vinicor, G.L. Robertson, Plasma vasopressin in uncontrolled diabetes mellitus, Diabetes 28 (1979) 503-508.
30. U. Saleem, M. Khaleghi, N.G. Morgenthaler, A. Bergmann, J. Struck, T.H. Mosley, et al., Plasma carboxy-terminal provasopressin (copeptin): a novel marker of insulin resistance and metabolic syndrome, J. Clin. Endocrinol. Metab. 94 (2009) 2558-2564.
31. H. Narayan, O.S. Dhillon, P.A. Quinn, J. Struck, I.B. Squire, J.E. Davies, et al., C-terminal provasopressin (copeptin) as a prognostic marker after acute non-ST elevation myocardial infarction: Leicester Acute Myocardial Infarction Peptide II (LAMP II) study, Clin. Sci. (Lond.) 121 (2011) 79-89.
32. A.A. Voors, S. von Haehling, S.D. Anker, H.L. Hillege, J. Struck, O. Hartmann, et al., C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study, Eur. Heart J. 30 (2009) 1187-1194.
33. C. Then, B. Kowall, A. Lechner, C. Meisinger, M. Heier, W. Koenig, et al., Plasma copeptin levels are inversely associated with intima-media-thickness in men: the population-based KORA F4 study, Cardiovasc. Diabetol. 12 (2013) 168.
34. W. Hochholzer, T. Reichlin, R. Twerenbold, C. Stelzig, K. Hochholzer, J. Meissner, et al., Incremental value of high-sensitivity cardiac troponin T for risk prediction in patients with suspected acute myocardial infarction, Clin. Chem. 57 (2011) 1318-1326.
35. M. Bonaca, B. Scirica, M. Sabatine, A. Dalby, J. Spinar, S.A. Murphy, et al., Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I, J. Am. Coll. Cardiol. 55 (2010) 2118-2124.
36. P.A. Kavsak, X. Wang, D.T. Ko, A.R. MacRae, A.S. Jaffe, Short- and long-term risk stratification using a next-generation, high-sensitivity research cardiac troponin I (hscTnI) assay in an emergency department chest pain population, Clin. Chem. 55 (2009) 1809-1815.
37. L. Cullen, W.A. Parsonage, J. Greenslade, A. Lamanna, C.J. Hammett, M. Than, et al., Delta troponin for the early diagnosis of AMI in emergency patients with chest pain, Int. J. Cardiol. 168 (2013) 2602-2608.
38. T. Keller, T. Zeller, D. Peetz, S. Tzikas, A. Roth, E. Czyz, et al., Sensitive troponin I assay in early diagnosis of acute myocardial infarction, N. Engl. J. Med. 361 (2009) 868-877.
39. N.L. Mills, K.K. Lee, D.A. McAllister, A.M. Churchhouse, M. Macleod, M. Stoddart, et al., Implications of lowering threshold of plasma troponin concentration in diagnosis of myocardial infarction: cohort study, BMJ 344 (2012) e1533.